BOTHELL, WA, -- MDRNA, Inc. (NASDAQ: MRNA) announced today that it has entered into a licensing agreement with Novartis for MDRNA's liposomal technology...Full story at www.prmediainc.com
read more | digg story
Subscribe to:
Post Comments (Atom)

No comments:
Post a Comment